SIT Group takes part in the international exhibition of the pharmaceutical world: CPhI Worldwide from 24 to 26 october 2023 in Barcelona, Spain, stand 2N30.

SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.

SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.

SIT Group is pleased to announce the acquisition of Natifar and Natimed brands from Laboratorios BIAL as a result of the agreement signed on October 25th, 2022.

The European Business magazine interviewed Lamberto Pedrotti, Managing Director of SIT Group.